Intensity Therapeutics Inc. has announced a 1-for-25 reverse stock split of its common stock, effective February 18, 2026. The company's shares will begin trading on a split-adjusted basis under the ticker symbol "INTS" on February 19, 2026. The move is intended to increase the per share trading price and help the company regain compliance with Nasdaq's minimum bid price requirement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intensity Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE87098) on February 13, 2026, and is solely responsible for the information contained therein.